Related Substances Method Validation - Limit of quantitation

When validating a new drug product Related Substances Method - I have seen methods where LOQ solutions have been prepared and simply injected as is but also have seen LOQ solutions prepared and injected in Mobile Phase and Placebo.

Can it be explained the rationale behind spiking into Mobile Phase or Placebo Please?